BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lodhia N, Rao S. Updates in therapeutic drug monitoring in inflammatory bowel disease. World J Gastroenterol 2022; 28(21): 2282-2290 [PMID: 35800180 DOI: 10.3748/wjg.v28.i21.2282]
URL: https://www.wjgnet.com/1007-9327/full/v28/i21/2282.htm
Number Citing Articles
1
Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Eirini Theodoraki, Ioannis E. Koutroubakis. Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel DiseaseJournal of Clinical Medicine 2023; 12(7): 2452 doi: 10.3390/jcm12072452
2
Yoav Hershkovitz, Israel Khanimov, Limor Rubin, Zvika Dranitzki, Aviv Talmon, Yaarit Ribak, Oded Shamriz, Asi Levi, Yuval Tal. Successful ligelizumab treatment of severe refractory solar urticariaThe Journal of Allergy and Clinical Immunology: In Practice 2023; 11(8): 2576 doi: 10.1016/j.jaip.2023.01.052
3
Agata Michalak, Beata Kasztelan-Szczerbińska, Halina Cichoż-Lach. Impact of Obesity on the Course of Management of Inflammatory Bowel Disease—A ReviewNutrients 2022; 14(19): 3983 doi: 10.3390/nu14193983